|
|
my account
log out
|
CAS 4271-30-1 N-(4-Aminobenzoyl)-L-Glutamic Acid/sherry@chembj.com |
| Create: 12/12/2016 |
| Expired Date: | 12/11/2017 |
| Category: | Raw materials [Health&Medical&Pharmaceutical] |
| Message: | CAS 4271-30-1 N-(4-Aminobenzoyl)-L-Glutamic Acid/sherry@chembj.com Product Name: N-(4-Aminobenzoyl)-L-Glutamic Acid CAS: 4271-30-1 MF: C12H14N2O5 MW: 266.24996 Melting Point:175℃ (dec.) Boiling Point:607.1 °C at 760 mmHg Flash Point:320.9 °C Purity: >99% Appearance: Beige Crystalline Powder Application: Synthesize folic acid. Density:1.418 g/cm3 XLogP3-AA:0 H-Bond Donor:4 H-Bond Acceptor:6 Rotatable Bond Count:6 Tautomer Count:5 Exact Mass:266.090272 MonoIsotopic Mass:266.090272 Topological Polar Surface Area:130 Heavy Atom Count:19 Formal Charge:0 Complexity:350 Isotope Atom Count:0 Defined Atom Stereocenter Count:0 Undefined Atom Stereocenter Count:1 Defined Bond Stereocenter Count:0 Undefined Bond Stereocenter Count:0 Covalently-Bonded Unit Count:1 Feature 3D Acceptor Count:5 Feature 3D Donor Count:2 Feature 3D Anion Count:2 Feature 3D Cation Count:1 Feature 3D Ring Count:1 Effective Rotor Count:7 Conformer Sampling RMSD:0.8 |
![]() | |
| City: | Jinan Shandong[CN]
|
| Location: |
|
| Feb 20 2017 | Local Anaesthesia Tetracaine HCl/sherry@chembj.com | 495 | |
| Feb 20 2017 | Pharmaceutical Material DHEA Acetate/sherry@chembj.com | 758 | |
| Jan 13 2017 | Pharmaceutical Nootropic Drug Piracetam/sherry@chembj.com | 493 | |
| Jan 13 2017 | Pharmaceutical Solvent Tween 80/sherry@chembj.com | 511 | |
| Jan 13 2017 | Pharmaceutical Solvent Guaiacol/sherry@chembj.com | 515 | |
| Jan 13 2017 | Pharmaceutical Solvent Grape Seed Oil/sherry@chembj.com | 505 | |
| Jan 13 2017 | Pharmaceutical Solvent Ethyl Oleate/sherry@chembj.com | 495 | |
| Jan 13 2017 | Pharmaceutical Solvent Benzyl Benzoate/sherry@chembj.com | 506 | |
| Jan 13 2017 | Pharmaceutical Solvent Benzyl Alcohol/sherry@chembj.com | 498 | |
| Jan 13 2017 | Bodybuilding TUDCA Tauroursodeoxycholic Acid/sherry@chembj.com | 517 |
| Copyright © toextrade Inc. All rights reserved. Contact us |